144313-54-2

Valorphin exhibits pronounced analgesic activity in mice, rats and rhesus monkeys via s.c, with ED₅₀s of ≤5.2 mg/kg, but barely active after oral administration^[1]. Valorphin (1 mg/kg) causes 42% of tumor growth inhibition in female BLRB mice bearing syngeneic mammary carcinoma cells^[2].